Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -182.98% of over the last 5 years
The company has declared Negative results for the last 12 consecutive quarters
Risky - Negative Operating Profits
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 539 Cr (Micro Cap)
NA (Loss Making)
47
0.32%
0.30
-0.91%
1.43
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Faces Bearish Momentum Amid Technical Downturn
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent uptick in price, the overall technical landscape suggests caution for investors as bearish signals intensify across multiple timeframes.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 May 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 13 July 2026, providing investors with the latest view on the company’s position.
Read full news article
Chemfab Alkalis Ltd Technical Momentum Shifts Amid Mixed Market Signals
Chemfab Alkalis Ltd has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent 4.99% intraday gain, the stock remains under pressure with a strong sell rating from MarketsMOJO, underscoring the challenges facing this micro-cap commodity chemicals player.
Read full news article Announcements 
Chemfab Alkalis Limited - Other General Purpose
04-Nov-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange that Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities
Chemfab Alkalis Limited - Outcome of Board Meeting
31-Oct-2019 | Source : NSEChemfab Alkalis Limited has informed the Exchange regarding Board meeting held on October 30, 2019.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.7%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 9.74% vs -11.00% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 110.79% vs -121.39% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025
YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025






